FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

719375007: Sebelipase alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3316126019 Sebelipase alfa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3316127011 Sebelipase alfa en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sebelipase alfa Is a Peptide false Inferred relationship Existential restriction modifier
Sebelipase alfa Is a Substance with enzyme mechanism of action false Inferred relationship Existential restriction modifier
Sebelipase alfa Has disposition Enzyme false Inferred relationship Existential restriction modifier
Sebelipase alfa Is a Recombinant protein true Inferred relationship Existential restriction modifier
Sebelipase alfa Is a Substance with hydrolase mechanism of action true Inferred relationship Existential restriction modifier
Sebelipase alfa Has disposition Hydrolase true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing sebelipase alfa Has active ingredient True Sebelipase alfa Inferred relationship Existential restriction modifier 1
Product containing sebelipase alfa in parenteral dose form (medicinal product form) Has active ingredient True Sebelipase alfa Inferred relationship Existential restriction modifier 1
Sebelipase alfa Has active ingredient True Sebelipase alfa Inferred relationship Existential restriction modifier 1
Product containing only sebelipase alfa in parenteral dose form (medicinal product form) Has active ingredient True Sebelipase alfa Inferred relationship Existential restriction modifier 1
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has specific active ingredient True Sebelipase alfa Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has specific active ingredient True Sebelipase alfa Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) Has specific active ingredient True Sebelipase alfa Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Sebelipase alfa Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start